|
|
|
|
|
Click Here to return To Results
|
|
|
|
In a prospective study,we compared the number of gadolinium-DTPA(Gd-DTPA) enhancing lesions on MRI with the CSF and clinical findings before and after a total of 20 courses of high-dose intravenous methylprednisolone in relapsing multiple sclerosis patients.Before treatment,there was a significant correlation of Gd-DTPA enhancement(seen on 16 of 20 scans)and CSF myelin basic protein(MBP).If enhancement with Gd-DTPA represents inflammation and CSF-MBP indicates myelin breakdown,the amount of inflamed tissue should correlate with the amount of myelin being damaged.Clinical improvement occurred following 15 of 20 courses,and decrease of Gd-DTPA enhancement in 12 of 16 scans;the mean CSF-MBP level was the only CSF variable to return to reference values.There was a significant correlative triad of decrease in CSF-MBP,Gd-DTPA enhancement,and clinical disability. Thus,the clinical effect of methylprednisolone might be accompanied by a reduction of inflammation and myelin breakdown. |
|
(click to filter results - removes previous filter)
cerebrospinal fluid,abnormal
disability,neurological
gadolinium
MRI
MRI,abnormal
MRI,contrast enhanced
multiple sclerosis
multiple sclerosis,disability status scale
multiple sclerosis,relapsing
multiple sclerosis,treatment of
myelin basic protein
steroid
steroid therapy,CNS treatment and complications with
treatment of neurologic disorder
|
Click Here to return To Results
|
|